0QCV.L
AbbVie Inc. operates as a global pharmaceutical enterprise, concentrating on the discovery, development, production, and commercialization of medicinal products across the world. Its extensive product portfolio addresses various therapeutic areas. For autoimmune and inflammatory conditions, the company provides HUMIRA, an injectable treatment for autoimmune and intestinal Behçet's diseases; SKYRIZI, aimed at adults with moderate to severe plaque psoriasis; and RINVOQ, a JAK inhibitor prescribed for moderate to severe active rheumatoid arthritis in adult patients. In oncology, AbbVie offers IMBRUVICA for adult patients diagnosed with chronic lymphocytic leukemia (CLL) and small lymphocytic ly...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2013-04-08
Stock Exchange
LSE
Ticker
0QCV.L
According to AbbVie Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 128.74. This represents a change of -36.27% compared to the average of 202.00 of the last 4 quarters.
The mean historical PE Ratio of AbbVie Inc. over the last ten years is 39.97. The current 128.74 PE Ratio has changed 32.11% with respect to the historical average. Over the past ten years (40 quarters), 0QCV.L's PE Ratio was at its highest in in the December 2020 quarter at 2.37K. The PE Ratio was at its lowest in in the December 2024 quarter at -2454.42.
Average
39.97
Median
27.10
Minimum
16.71
Maximum
96.41
Discovering the peaks and valleys of AbbVie Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 134.94%
Maximum Annual PE Ratio = 96.41
Minimum Annual Increase = -46.76%
Minimum Annual PE Ratio = 16.71
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 96.41 | 30.21% |
| 2024 | 74.04 | 30.43% |
| 2023 | 56.77 | 133.58% |
| 2022 | 24.30 | 16.31% |
| 2021 | 20.90 | -46.76% |
| 2020 | 39.25 | 134.94% |
| 2019 | 16.71 | -33.13% |
| 2018 | 24.98 | -14.49% |
| 2017 | 29.22 | 70.30% |
| 2016 | 17.16 | -8.77% |
The current PE Ratio of AbbVie Inc. (0QCV.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
75.74
5-year avg
54.48
10-year avg
39.97
AbbVie Inc.’s PE Ratio is greater than Bristol-Myers Squibb Company (14.02), less than Meridian Bioscience, Inc. (0), greater than Patterson Companies, Inc. (15.66), greater than DMK Pharmaceuticals Corporation (-0.00), greater than Endo International plc (-0.15), greater than Walgreens Boots Alliance, Inc. (-1.20), greater than QuidelOrtho Corporation (-0.76), greater than bluebird bio, Inc. (-0.20), greater than Unity Biotechnology, Inc. (-0.13), greater than Evolus, Inc. (-15.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| 14.02 | N/A | |
| 0 | N/A | |
| 15.66 | N/A | |
| -0.00 | N/A | |
| -0.15 | N/A | |
| -1.20 | N/A | |
| -0.76 | N/A | |
| -0.20 | N/A | |
| -0.13 | N/A | |
| -15.14 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is AbbVie Inc.'s PE Ratio?
How is the PE Ratio calculated for AbbVie Inc. (0QCV.L)?
What is the highest PE Ratio for AbbVie Inc. (0QCV.L)?
What is the 3-year average PE Ratio for AbbVie Inc. (0QCV.L)?
What is the 5-year average PE Ratio for AbbVie Inc. (0QCV.L)?
How does the current PE Ratio for AbbVie Inc. (0QCV.L) compare to its historical average?